Ceragenix Atty Sued Over Whistleblower's Ouster

Law360, New York (June 4, 2012, 1:26 PM EDT) -- Former Ceragenix Pharmaceuticals Inc. executive Carl Genberg launched a malpractice suit Friday against an attorney who allegedly encouraged the bankrupt medical device company to fire him in retaliation for reporting insider trading.

Defendant Marc Redlich, a Boston-based attorney, conducted an investigation in March 2010 for Ceragenix that concluded Genberg had violated his fiduciary obligations to the company, according to a complaint in Colorado federal court. Based on the report, Ceragenix fired Genberg from his position as senior vice president of research and development, the complaint said....
To view the full article, register now.




Case Information

Case Title

Genberg v. Redlich

Case Number




Nature of Suit

P.I.: Other


David M. Ebel

Date Filed

May 31, 2012

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.